Table 1 |
|||||
|
Gene ontology (GO) analysis of genes differentially expressed in control and proteoglycan-induced spondylitis (PGISp) mouse spines |
|||||
|
GO category |
GO term |
Number of genes |
LS permutation P-value |
KS permutation P-value |
Efron-Tibshirani's GSA test P-value |
|
|
|||||
|
GO:0002252 |
immune effector process |
225 |
0.00001 |
0.00196 |
< 0.005 (+) |
|
GO:0002376 |
immune system process |
995 |
0.00001 |
0.00002 |
0.005 (+) |
|
GO:0002444 |
myeloid leukocyte mediated immunity |
18 |
0.00001 |
0.00179 |
0.005 (+) |
|
GO:0002682 |
regulation of immune system process |
374 |
0.00001 |
0.01936 |
0.005 (+) |
|
GO:0002684 |
positive regulation of immune system process |
255 |
0.00001 |
0.00417 |
0.005 (+) |
|
GO:0006954 |
inflammatory response |
293 |
0.00001 |
0.00007 |
< 0.005 (+) |
|
GO:0006955 |
immune response |
562 |
0.00001 |
0.00001 |
0.005 (+) |
|
GO:0032963 |
collagen metabolic process |
30 |
0.00007 |
0.01778 |
0.005 (+) |
|
Osteoblast genes |
16 |
0.00105 |
0.00005 |
0.02 (+) |
|
|
|
|||||
|
Gene expression levels in a number of inflammatory pathways, as well as an osteoblast gene set are altered in PGISp spine samples. LS, log summary; KS, Kolmogorov-Smirnov summary; GSA, gene set analysis. |
|||||
|
Haynes et al. Arthritis Research & Therapy 2012 14:R253 doi:10.1186/ar4096 |
|||||